Name | SGL5213 |
---|
Description | SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. SGL5213 has potential to treat type 2 diabetes treatment[1]. |
---|---|
Related Catalog | |
Target |
IC50: 29nM/20 nM (hSGLT1/ hSGLT2)[1]. |
References |
Molecular Formula | C37H55N3O8 |
---|---|
Molecular Weight | 669.85 |